Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors.
Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for ...
Eli Lilly's next generation weight loss drug shows promise, early trial results suggest
Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...
Where the blockbuster weight loss drug market stands today — and what’s coming next
Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.
Obesity Drugs May Drop to as Little as $149 a Month
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals
Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have ...
Eli Lilly, Novo Nordisk Cut Weight-Loss Drug Prices in Deals With Trump Administration
Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, ...
EconoTimes
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Shares in Novo Nordisk dropped nearly 3% on Friday after the Danish pharmaceutical giant and U.S. competitor Eli Lilly agreed ...
NBC Connecticut
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
Baillies, a human resources specialist based in Milwaukee, Wisconsin, has been attempting to lose weight and dealing with chronic autoimmune issues for years, so she turned to a cheaper alternative: a ...
New York Sun
Judge Dismisses Eli Lilly Lawsuit Against ‘Godsend’ Makers of Compounded GLP-1 Weight Loss Drugs
A Delaware federal judge dismissed a lawsuit brought by Eli Lilly, the maker of the blockbuster weight loss drugs Mounjaro and Zepbound, against a telehealth company it accused of “deceptive” ...